Trial intelligence / Profile preview

Bupivacaine for Pain in Pediatric Cardiac Catheterization

NCT01133119Phase 2Completed

Sponsor
SickKids
Start
Feb 2010
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in pain comparing Standard of Care with Bupivacaine (2 arms). Primary endpoint: Self-reported levels of pain at 6 hours. Started Feb 2010; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

pain

Beyond the preview

Go deeper on NCT01133119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01133119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call